美国内分泌外科医师协会:继发性和三发性肾性甲状旁腺功能亢进确定性手术管理指南
该指南由美国内分泌外科医师协会制定,针对慢性肾脏病、终末期肾病及肾移植患者的继发性(SHPT)和三发性(THPT)肾性甲状旁腺功能亢进,基于1985年至2021年的文献证据,采用美国内科医师学会分级系统,经专家共识形成推荐,涵盖术前评估、手术方式、围术期管理及再手术等。
要点
- SHPT和THPT手术管理需多学科协作,指南覆盖术前评估至术后管理全流程。
- 推荐基于1985-2021年文献证据,采用美国内科医师学会分级系统确定证据等级。
- 指南涉及影像学、手术规划、甲状旁腺切除术式及辅助手段等关键环节。
核心结论
- 基于证据的指南旨在帮助临床医生优化继发性和三发性肾性甲状旁腺功能亢进的管理。
研究设计与样本
- 由10名SHPT和THPT专家组成的小组回顾1985年1月1日至2021年1月1日的医学文献,采用美国内科医师学会分级系统构建推荐,经共识讨论及协会成员评议。
主要发现
- 指南呈现了SHPT和THPT的流行病学和病理生理学,并为所有相关临床医生提供了检查和管理推荐。
- 指南概述了术前、术中、术后管理及相关定义、手术技术、并发症和结局。
- 具体主题包括发病机制与流行病学、初始评估、影像学、术前和围术期护理、手术规划与甲状旁腺切除术、辅助手段与方法、结局及再手术。
临床怎么用
- 临床医生可依据指南进行SHPT和THPT的术前评估、手术决策、围术期管理及再手术规划。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop evidence-based recommendations for safe, effective, and appropriate treatment of secondary (SHPT) and tertiary (THPT) renal hyperparathyroidism. BACKGROUND: Hyperparathyroidism is common among patients with chronic kidney disease, end-stage kidney disease, and kidney transplant. The surgical management of SHPT and THPT is nuanced and requires a multidisciplinary approach. There are currently no clinical practice guidelines that address the surgical treatment of SHPT and THPT. METHODS: Medical literature was reviewed from January 1, 1985 to present January 1, 2021 by a panel of 10 experts in SHPT and THPT. Recommendations using the best available evidence was constructed. The American College of Physicians grading system was used to determine levels of evidence. Recommendations were discussed to consensus. The American Association of Endocrine Surgeons membership reviewed and commented on preliminary drafts of the content. RESULTS: These clinical guidelines present the epidemiology and pathophysiology of SHPT and THPT and provide recommendations for work-up and management of SHPT and THPT for all involved clinicians. It outlines the preoperative, intraoperative, and postoperative management of SHPT and THPT, as well as related definitions, operative techniques, morbidity, and outcomes. Specific topics include Pathogenesis and Epidemiology, Initial Evaluation, Imaging, Preoperative and Perioperative Care, Surgical Planning and Parathyroidectomy, Adjuncts and Approaches, Outcomes, and Reoperation. CONCLUSIONS: Evidence-based guidelines were created to assist clinicians in the optimal management of secondary and tertiary renal hyperparathyroidism.
引用
- Dream S, Kuo LE, Kuo JH, et al. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism. Ann Surg. 2022. PMID: 35848728. doi:10.1097/SLA.0000000000005522
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。